Редактирование: Aging genes 5-9 (раздел)

==XRCC1==

* {{medline-title
|title=Impairment of Pol β-related DNA Base-excision Repair Leads to Ovarian Aging in Mice.
|date=20.11.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33223510
|full-text-url=https://sci-hub.do/10.18632/aging.104123
}}
* {{medline-title
|title=Base excision repair but not DNA double-strand break repair is impaired in aged human adipose-derived stem cells.
|date=02.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31782607
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996963
}}
* {{medline-title
|title=[Protective effect of Wuzi Yanzong recipe on testicular DNA oxidative damage in natural ageing rats].
|date=07.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30111059
|full-text-url=https://sci-hub.do/10.19540/j.cnki.cjcmm.20180408.005
}}
* {{medline-title
|title=The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity.
|date=2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30008586
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036081
}}
* {{medline-title
|title=[[XRCC1]] and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
|date=2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25873778
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384174
}}
* {{medline-title
|title=Polymorphisms of DNA repair genes XPD (Lys751Gln) and [[XRCC1]] (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
|date=07.2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25285569
|full-text-url=https://sci-hub.do/10.3109/02713683.2014.957325
}}
* {{medline-title
|title=Association between DNA repair genes (XPD and [[XRCC1]]) polymorphisms and susceptibility to age-related cataract ([[ARC]]): a meta-analysis.
|date=08.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24906341
|full-text-url=https://sci-hub.do/10.1007/s00417-014-2679-2
}}
* {{medline-title
|title=Polymorphisms in [[ERCC1]] C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.
|date=08.2013
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23712330
|full-text-url=https://sci-hub.do/10.1007/s00280-013-2196-8
}}